(Q36567729)

15 August 2017

1 reference

title

The new meningococcal conjugate vaccine. A profile of its safety, efficacy, and indications for use. (English)

1 reference

15 August 2017

Michael E Pichichero

1

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 June 2006

1 reference

15 August 2017

published in

Postgraduate Medicine

1 reference

15 August 2017

volume

119

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

47-54, 64

1 reference

Serogroup C meningococcal outbreaks in the United States. An emerging threat

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Meningococcal disease in college students

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Invasive meningococcal disease in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Impact of meningococcal C conjugate vaccine in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Efficacy of meningococcal vaccine and barriers to vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Modelling cost effectiveness of meningococcal serogroup C conjugate vaccination campaign in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Maternal and infant antibody response to meningococcal vaccination in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

Antibody response to serogroup A and C meningococcal polysaccharide vaccines in infants born of mothers vaccinated during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2006.06.1640

21 January 2018

Identifiers

DOI

10.3810/PGM.2006.06.1640

1 reference

15 August 2017

1 reference